{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:27:47Z","timestamp":1794932867615,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["9923686001"],"award-info":[{"award-number":["9923686001"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118027","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T21:09:12Z","timestamp":1743541752000},"page":"118027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Valproic acid preconditioning of bone marrow mesenchymal stem cells promotes remyelination of the corpus callosum in a cuprizone-induced demyelination model"],"prefix":"10.1016","volume":"186","author":[{"given":"Golaleh","family":"Noorzehi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parichehr","family":"Pasbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameneh","family":"Alikarami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj Ragerdi","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5479-1168","authenticated-orcid":false,"given":"Sina","family":"Mojaverrostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118027_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21741","article-title":"Quercetin as a possible complementary therapy in multiple sclerosis: anti-oxidative, anti-inflammatory and remyelination potential properties","author":"Javanbakht","year":"2023","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.biopha.2025.118027_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10735-022-10092-8","article-title":"Combination effects of mesenchymal stem cells transplantation and anodal transcranial direct current stimulation on a cuprizone-induced mouse model of multiple sclerosis","volume":"53","author":"Mojaverrostami","year":"2022","journal-title":"J. Mol. Histol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118027_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/antiox13080914","article-title":"Evidence for TGF-\u03b21\/Nrf2 signaling crosstalk in a cuprizone model of multiple sclerosis","volume":"13","author":"Guevara","year":"2024","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.biopha.2025.118027_bib4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/ijms25031445","article-title":"How to Use the Cuprizone Model to Study De-and Remyelination","volume":"25","author":"Kipp","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118027_bib5","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1097\/MS9.0000000000001127","article-title":"Remyelination in multiple sclerosis, along with its immunology and association with gut dysbiosis, lifestyle, and environmental factors","volume":"85","author":"Prajjwal","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.biopha.2025.118027_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2018.11.015","article-title":"Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: focus on mesenchymal stem cells and neuroprotection","volume":"328","author":"Yousefi","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118027_bib7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/biology10111142","article-title":"Cell therapy for neurological disorders: the perspective of promising cells","volume":"10","author":"Liu","year":"2021","journal-title":"Biology"},{"issue":"22","key":"10.1016\/j.biopha.2025.118027_bib8","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.3390\/ijms21228662","article-title":"Mesenchymal stem cells in multiple sclerosis: recent evidence from pre-clinical to clinical studies","volume":"21","author":"Gugliandolo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118027_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2020.102095","article-title":"Effects of mesenchymal stem cells transplantation on multiple sclerosis patients","volume":"84","author":"Barati","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopha.2025.118027_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-02032-8","article-title":"Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells","volume":"11","author":"Wang","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118027_bib11","first-page":"4759492","article-title":"Potential of bone-marrow-derived mesenchymal stem cells for maxillofacial and periodontal regeneration: a narrative review","volume":"2021","author":"Khorasani","year":"2021","journal-title":"Int. J. Dent."},{"issue":"1","key":"10.1016\/j.biopha.2025.118027_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3350\/cmh.2020.0194","article-title":"The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future","volume":"27","author":"Watanabe","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118027_bib13","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3390\/ijms23042088","article-title":"Mesenchymal stromal cells preconditioning: a new strategy to improve neuroprotective properties","volume":"23","author":"Schepici","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118027_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jcmm.14769","article-title":"Melatonin preconditioning is an effective strategy for mesenchymal stem cell-based therapy for kidney disease","volume":"24","author":"Zhao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118027_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.physbeh.2018.11.034","article-title":"Dimethyloxalylglycine preconditioning enhances protective effects of bone marrow-derived mesenchymal stem cells in A\u03b2-induced Alzheimer disease","volume":"199","author":"Esmaeilzade","year":"2019","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.biopha.2025.118027_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1167\/iovs.09-3903","article-title":"Valproic acid\u2013mediated neuroprotection and regeneration in injured retinal ganglion cells","volume":"51","author":"Biermann","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2025.118027_bib17","doi-asserted-by":"crossref","DOI":"10.4274\/balkanmedj.galenos.2024.2024-6-25","article-title":"Preconditioning of human umbilical cord mesenchymal stem cells with a histone deacetylase inhibitor: valproic acid","author":"I\u015f\u0131ldar","year":"2024","journal-title":"Balk. Med. J. 41(5"},{"issue":"1","key":"10.1016\/j.biopha.2025.118027_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/1673-5374.264455","article-title":"Mesenchymal stem cells secretome: current trends and future challenges","volume":"15","author":"Teixeira","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2025.118027_bib19","series-title":"Influence of Preconditioning on the Homing Behavior of Stem Cells, Regenerative Therapies in Ischemic Stroke Recovery","first-page":"199","author":"Shamsh","year":"2022"},{"key":"10.1016\/j.biopha.2025.118027_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11748-021-01696-0","article-title":"Modifying strategies for SDF-1\/CXCR4 interaction during mesenchymal stem cell transplantation","author":"Jiang","year":"2022","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.biopha.2025.118027_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151097","article-title":"Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier","volume":"99","author":"Shariati","year":"2020","journal-title":"Eur. J. Cell Biol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118027_bib22","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.3390\/ijms23073829","article-title":"Mesenchymal stem cell-derived extracellular vesicles and their therapeutic use in central nervous system demyelinating disorders","volume":"23","author":"Allegretta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118027_bib23","article-title":"Deferoxamine preconditioning enhances the protective effects of stem cells in streptozotocin-induced Alzheimer's disease","volume":"287","author":"Asl","year":"2021","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118027_bib24","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3390\/cells9102218","article-title":"Short-term rapamycin preconditioning diminishes therapeutic efficacy of human adipose-derived stem cells in a murine model of multiple sclerosis","volume":"9","author":"Wise","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118027_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.109985","article-title":"Human Wharton's jelly-derived mesenchymal stromal stem cells preconditioned with valproic acid promote cell migration and reduce renal inflammation in ischemia\/reperfusion injury by activating the AKT\/P13K and SDF1\/CXCR4 pathways","volume":"755","author":"Shokeir","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.biopha.2025.118027_bib26","article-title":"Migration, proliferation, and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic acid","volume":"2014","author":"Marquez-Curtis","year":"2014","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.biopha.2025.118027_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13287-022-03011-x","article-title":"Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha","volume":"13","author":"Jiang","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118027_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7555\/JBR.36.20210109","article-title":"Valproic acid enhances neurosphere formation in cultured rat embryonic cortical cells through TGF\u03b21 signaling","volume":"36","author":"Qi","year":"2022","journal-title":"J. Biomed. Res."},{"issue":"11","key":"10.1016\/j.biopha.2025.118027_bib29","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/term.2219","article-title":"Valproic acid enhances the neural differentiation of human placenta derived-mesenchymal stem cells in vitro","volume":"11","author":"Talwadekar","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.biopha.2025.118027_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4274\/balkanmedj.galenos.2024.2024-6-25","article-title":"Preconditioning of human umbilical cord mesenchymal stem cells with a histone deacetylase inhibitor: valproic acid","author":"I\u015f\u0131ldar","year":"2024","journal-title":"Balk. Med. J. 41(5"},{"issue":"1","key":"10.1016\/j.biopha.2025.118027_bib31","first-page":"578","article-title":"Wnt signaling pathway participates in valproic acid-induced neuronal differentiation of neural stem cells","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118027_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5582\/bst.8.111","article-title":"Transplantation of bone marrow mesenchymal stem cells pretreated with valproic acid in rats with an acute spinal cord injury","volume":"8","author":"Chen","year":"2014","journal-title":"Biosci. Trends"},{"issue":"12","key":"10.1016\/j.biopha.2025.118027_bib33","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/jcb.24615","article-title":"Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney","volume":"114","author":"Liu","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2025.118027_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13770-018-0163-5","article-title":"GM-CSF enhances mobilization of bone marrow mesenchymal stem cells via a CXCR4-medicated mechanism","volume":"16","author":"Kim","year":"2019","journal-title":"Tissue Eng. Regen. Med."},{"issue":"24","key":"10.1016\/j.biopha.2025.118027_bib35","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.1006375107","article-title":"Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis","volume":"107","author":"Carbajal","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118027_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155706","article-title":"Involvement of various chemokine\/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal stem cells in multiple sclerosis patients","volume":"148","author":"Hassanshahi","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2025.118027_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154541","article-title":"Application of mesenchymal stem cells (MSCs) in neurodegenerative disorders: history, findings, and prospective challenges","volume":"247","author":"Biglari","year":"2023","journal-title":"Pathol. -Res. Pract."},{"issue":"10","key":"10.1016\/j.biopha.2025.118027_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/cells13100845","article-title":"Preconditioning of MSCs for acute neurological conditions: from cellular to functional impact\u2014a systematic review","volume":"13","author":"Serrenho","year":"2024","journal-title":"Cells"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:54:29Z","timestamp":1781823269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"alternative-id":["S0753332225002215"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118027","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid preconditioning of bone marrow mesenchymal stem cells promotes remyelination of the corpus callosum in a cuprizone-induced demyelination model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118027"}}